https://www.wsj.com/articles/chinas-sinovac-covid-19-vaccine-is-50-4-in-late-stage-brazil-trials-11610470581
Results in late-stage testing of Sinovac shot were almost 30 percentage points lower than previously announced, as concerns grow over the study’s transparency.
Chinese Covid-19 Vaccine Is Far Less Effective Than Initially Touted in Brazil
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- It’s Time to Reimagine Scale
- How to Be Systematic About Adopting AI at Your Company
- 25 Tech and Infrastructure Problems to Solve Before We Can Reach Net Zero
- Ethical AI and the Pursuit of Progressive Human Innovation in Canada
- Why Isn’t Healthcare More Personalized?
- Britain ponders an innovative invitation to bond markets: give us your money forever
- Remembering an unconventional democrat and scholar of Walter Bagehot’s works
- Signalling a left turn, or just pandering? Nick Clegg blames the Labour government for not spending enough
- David Cameron’s race problem
- Health and safety madness: a menace with ancient British roots
More from UncategorizedMore posts in Uncategorized »
- It’s Time to Reimagine Scale
- How to Be Systematic About Adopting AI at Your Company
- 25 Tech and Infrastructure Problems to Solve Before We Can Reach Net Zero
- Ethical AI and the Pursuit of Progressive Human Innovation in Canada
- Why Isn’t Healthcare More Personalized?
- Britain ponders an innovative invitation to bond markets: give us your money forever
- Remembering an unconventional democrat and scholar of Walter Bagehot’s works
- Signalling a left turn, or just pandering? Nick Clegg blames the Labour government for not spending enough
- David Cameron’s race problem
- Health and safety madness: a menace with ancient British roots